🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nowy Sącz
Clinical trial register · Poland

Clinical Trials in Nowy Sącz, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2681 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2681
Studies in scope
all four open statuses
1400
Recruiting now
open to new participants
514
Lead sponsors
across recruiting studies
Top sites
Warsaw 1297 Krakow 869 Poznan 699 Gdansk 656 Lodz 622
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw1297 Krakow869 Poznan699 Gdansk656 Lodz622
All 261 locations
Target enrolment
to

Trials with a site in Nowy Sącz

11 of 2681 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions
NCT07330622Coronary Occlusion, Percutaneous Coronary Intervention
National Institute of Cardiology, Warsaw, Poland
Observational
1,000
Bialystok, Grodzisk Mazowiecki, Inowrocław, Katowice, Krakow, Lubin, Lublin, Nowy Sącz
2025-05-21
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
NCT06544499Primary Immune Thrombocytopenia (ITP)
argenx
Phase 3
69
Bydgoszcz, Katowice, Lodz, Lublin, Nowy Sącz, Torun
2024-10-18
Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
NCT06479135Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis, Primary Myelofibrosis
Kartos Therapeutics, Inc.
Phase 3
600
Bialystok, Gdansk, Krakow, Lodz, Nowy Sącz, Olsztyn, Poznan, Szczecin
2024-06-03
Recruiting
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
NCT05304377Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml
Enliven Therapeutics
Phase 1
250
Nowy Sącz, Torun, Warsaw
2022-05-22
Active, closed
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
NCT04812925Primary Immune Thrombocytopenia
argenx
Phase 3
173
Katowice, Nowy Sącz, Skorzewo
2021-11-17
Active, closed
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
NCT04509700B-Cell Malignancies
Incyte Corporation
Phase 2
112
Kracow, Lodz, Nowy Sącz, Wroclaw
2020-08-03
Active, closed
Functional Assessment in Elderly MI Patients With Multivessel Disease
NCT03772743Myocardial Infarction
Consorzio Futuro in Ricerca
Not applicable
1,445
Krosno, Nowy Sącz, Oświęcim, Pińczów, Sanok
2019-07-15
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum
Phase 3
407
Bialystok, Gdansk, Katowice, Krakow, Lodz, Lublin, Nowy Sącz, Rzeszów
2017-06-26
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-poland/city/nowy-s-cz

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,681 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Nowy Sącz.

How many clinical trials are recruiting in Nowy Sącz?

5 of the 11 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nowy Sącz), 11 studies
PhaseStudiesRecruitingShare
Phase 36254.5%
Phase 22118.2%
Not applicable109.1%
Observational119.1%
Phase 1119.1%

Most active sponsors

Lead sponsors with the most studies (Nowy Sącz)
Lead sponsorStudiesRecruiting
argenx21
Celgene10
Consorzio Futuro in Ricerca10
Enliven Therapeutics11
GlaxoSmithKline10
Incyte Corporation10
Kartos Therapeutics, Inc.11
Merck Sharp & Dohme LLC11
National Institute of Cardiology, Warsaw, Poland11
Swedish Orphan Biovitrum10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.